Product
Lokelma
2 clinical trials
5 indications
Indication
Chronic Kidney DiseaseIndication
HyperkalemiaIndication
HyperkalaemiaIndication
Mineralocorticoid-Resistant HyperkalemiaClinical trial
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).Status: Completed, Estimated PCD: 2022-01-12
Clinical trial
Lokelma for Maximisation of RAAS Inhibition in CKD Patients With Heart Failure; Randomised.Status: Recruiting, Estimated PCD: 2023-12-31